BridgeMD
New treatment option for Insomnia Chronic
Official title Sleep Well Despite Persistent Pain Symptoms
ClinicalTrials.gov ID: NCT06351839
What this study is testing
- What it's testing
- Background: The prevalence of comorbid insomnia is 8-10 times higher in patients with chronic pain than in the general population. Insomnia adds a considerable burden as it worsens the quality of life, restoration and repair, mental health and pain symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients who, after clinical examination at University hospital of Northern Norway (UNN) fill the criteria for a chronic non-malignant pain diagnosis...
- Satisfy criteria for a comorbid insomnia
- Both first-time referrals and former referred patients.
You likely can't join if
- A comorbid drug abuse diagnosis (ICD-10)
- An ongoing compensation and/or insurance case related to a health issue, illness or treatment
- Drug treatment using \>100 morphine equivalents
- Participation in other group-based treatments at the UNN Pain Department or the Physical Outpatient Medical Clinic (must be completed before...
The study team makes the final eligibility decision.
Where it's taking place
- Tromsø, Troms County, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tromsø, Troms County, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.